Polypoidal Choroidal Vasculopathy: Clinical Trials

4 trials for Polypoidal Choroidal Vasculopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 4

Follow Polypoidal Choroidal Vasculopathy: new trials by email Literature Review of Polypoidal Choroidal Vasculopathy trials Research Report on Polypoidal Choroidal Vasculopathy

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment
Aflibercept + reduced fluence photodynamic therapy (RF-PDT), Aflibercept + sham reduced fluence photodynamic therapy (RF-PDT) - Polypoidal Choroidal Vasculopathy
Not applicableCompletedSingapore National Eye Centre602021-02-012025-11-18
Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid
Aflibercept Injection - Choroidal Neovascularization, Choroid Disease
Not applicableCompletedAzienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo172017-09-182019-09-03
Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment
Intravitreal aflibercept - Polypoidal Choroidal Vasculopathy
Not applicableCompletedFondation Ophtalmologique Adolphe de Rothschild372014-01-012017-12-08
Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen
verteporfin, verteporfin and ranibizumab - Polypoidal Choroidal Vasculopathy
Not applicableCompletedSun Yat-sen University602012-12-012018-03-08

Narrower conditions

Choroid Diseases (1)  ·  Choroidal Neovascularization (1)

Broader conditions

Eye Diseases (4)  ·  Metaplasia (4)  ·  Neovascularization, Pathologic (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Uveal Diseases (4)  ·  Choroid Diseases (3)  ·  Choroidal Neovascularization (3)

Interventions

Verteporfin (3)  ·  aflibercept (2)  ·  Injections (1)  ·  Ranibizumab (1)

Sponsors

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo (1)  ·  Fondation Ophtalmologique Adolphe de Rothschild (1)  ·  Singapore National Eye Centre (1)  ·  Sun Yat-sen University (1)

Countries

China (1)  ·  France (1)  ·  Italy (1)  ·  Singapore (1)

Top investigators

Chenjin Jin, Ph.D. (1)  ·  Gemmy Cheung Chui Ming (1)  ·  Martine Mauget-Faysse (1)  ·  Salvatore Cillino, MD PhD (1)

Results publications

PMID 29925341, PMID 34266844, PMID 40146166